#Omicron variant
-
Study shows COVID vaccine effectiveness against Omicron drops dramatically after 6 months
-
New Omicron subvariant XBB.1.16 spreading in U.S.
-
Canada approves Moderna's Omicron-targeting bivalent for kids, teens
-
Azerbaijani Health Ministry talks new Omiсron subvariant infections
-
U.S. CDC concerned for new Omicron subvariants
-
BA.5 Omicron subvariant 4 times more vaccine-resistant: study
-
Omicron subvariant makes up nearly three quarters of new COVID-19 infections in U.S.
-
Iran Produces Vaccine against Omicron
-
Sweden recommends fourth COVID-19 jab for the elderly
-
Azerbaijan exceeds WHO vaccination threshold for both doses of COVID-19 vaccine - WHO
-
Azerbaijani Health Minister talks possible tightening of quarantine regime
-
Omicron BA.2 sub-variant cases in Israel double to 700
-
Omicron COVID-19 infections increase, whereas death rates remain unchanged in Azerbaijan
-
Turkish president tests positive for COVID-19
-
Booster dose of COVID-19 vaccine increases protection against Omicron strain for elders - Azerbaijan's Health Ministry
-
Azerbaijan strengthens control over detection of genetic COVID-19 strains - Health Ministry
-
Azerbaijan's Ministry of Health shares most common symptoms of Omicron COVID-19
-
Over 80 Russian regions report Omicron variant - crisis center
-
Omicron generated antibodies effective against all variants of concern in adolescents, adults: ICMR study
-
Azerbaijan says high infectiousness, short incubation period of Omicron strain lead to infection rate growth
-
S.Korea's daily COVID-19 cases surge as new testing scheme begins
-
Scientists take aim at Omicron
-
IMF downgrades 2022 global growth forecast to 4.4 pct amid Omicron surge
-
Pfizer, BioNTech start clinical trial of Omicron-specific COVID-19 vaccine
